
Adam May on $ABVX's blowout data and subsequent stock crash
About this episode
Abivax posted maybe the best ulcerative colitis data anyone's seen, then crashed 60% on a cancer signal Adam May argues is statistical noise. We dig into whether $ABVX is now a mispriced takeout: the maintenance efficacy that beat Rinvoq, how the scary "seven cancer cases" collapse to two, the blackbox question, the Crohn's skew, and the part two safety data due within weeks. Then a quick look at Nectar (NKTR), its alopecia areata data, and the Eli Lilly lawsuit.
This episode is sponsored by AlphaSense, and specifically Andrew's upcoming AI webinar with them: breaking down the modern AI stack for investors with Dave Wang (Wall Street Prompts) and Ben Collins (AlphaSense). Goes live June 25. Register here.
Chapters:
00:00 Intro and disclosure (long ABVX and NKTR)
01:03 Sponsor: AlphaSense AI webinar for investors
02:33 The biotech "GOAT" returns
03:33 Abivax setup: induction vs maintenance, the stakes
06:38 The bar: clinical remission and Rinvoq
10:14 Blowout maintenance data, and endoscopic remission that doubles Rinvoq
14:23 The data drops, then a 60% crash
16:31 The cancer scare, taken apart case by case
24:45 Why it's statistical noise: mechanism, clustering, base rates
28:50 Adverse-event capture and the phase 2 safety database
33:57 Bear case: hasn't the market had time to digest this?
38:00 Blackbox or no blackbox, and does it matter at $100
40:32 The Crohn's readout and the skew
45:36 M&A: timing, the new CCO, what Adam wants them to do
47:38 Part two safety data due within weeks
54:46 The cash question: secondary vs sale
57:49 Nectar: strong data, then an unexplained selloff
59:54 The Eli Lilly lawsuit and the jury-trial angle
01:03:26 Ox40 read-through and the Q32 Bio overhang
01:06:07 Most mispriced pick, targets, and the CEO's Cincor parallel
01:12:10 Wrap
Links:
Yet Another Value Blog - https://www.yetanothervalueblog.com
See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer
Production and editing by The Podcast Consultant - https://thepodcastconsultant.com/
Disclosure: Long ABVX and NKTR
Get every episode summarized
Each time Yet Another Value Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Yet Another Value Podcast

UK stocks are dirt cheap. Why won't the boards act? $ZIG $CRW | Undervalued-Shar...
Yet Another Value Podcast

Zack Buckley on $PRTH's take private
Yet Another Value Podcast

$TBBB: Tiendas 3B is Mexico's Aldi. Is it too late to buy? | Fruit Tree Capital
Yet Another Value Podcast

$LMB: Limbach missed the data center boom. Is that the opportunity? | 1 Main Cap...
Yet Another Value Podcast